A gene signature of response to radiotherapy in patients with grade II-III oligodendrogliomas.

Elizabeth Cohen-Jonathan Moyal,Julia Gilhodes,G. Peyraga,Emmanuelle Uro-Coste,Damien Pouessel,D Larrieu-Ciron,Catherine Carpentier,François Ducray,Caroline Dehais

A gene signature of response to radiotherapy in patients with grade II-III oligodendrogliomas.

2019

Elizabeth Cohen-Jonathan Moyal
Julia Gilhodes
G. Peyraga
Emmanuelle Uro-Coste
Damien Pouessel
D Larrieu-Ciron
Catherine Carpentier
François Ducray
Caroline Dehais

2041Background: Grade II and III Oligodendroglioma associate mutations of isocitrate deshydrogenase 1 or 2 genes and the whole-arm chromosomal loss of 1p and 19q and have a better prognosis than ot...

Keywords:

Oncology
Gene
Pathology
Radiation therapy
Internal medicine
Medicine
Oligodendroglioma
in patient
Chromosomal Loss

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations